M. Orth et al., Hemostatic factors in hypertriglyceridemic men: Effects of a fatty meal before and after triglyceride-lowering treatment with etofibrate, THROMB RES, 94(6), 1999, pp. 341-351
The aims of this double-blind study were to examine whether in hypertriglyc
eridemic men the ingestion of a standardized fatty meal alters hemostasis n
egatively and whether triglyceride-lowering treatment with etofibrate for 6
weeks alters fasting and postprandial hemostasis positively, thus reversin
g the potential negative effects of a fatty meal on postprandial hemostasis
. To answer these questions, we measured markers of hemostasis immediately
before a standardized fatty meal, and 4, 6, 8, and 10 hours after the meal
in 21 hypertriglyceridemic men both before and after treatment with etofibr
ate. We found that the concentration of plasmin alpha(2)antiplasmin complex
markedly increased for at least 10 hours after the fatty meal, but that th
e activation of factor XII and the concentration of prothrombin activation
fragment(1+2) decreased after the fatty meal. These results on factor XII c
ontradict reported in vitro data. Triglyceride-lowering treatment with etof
ibrate in 10 of these men for 6 weeks increased fasting and postprandial pr
otein C and plasminogen and also slightly decreased the activation of fXII;
however, it did not reverse the postprandial increase of PAP or change the
decrease of prothrombin activation fragment(1+2). Our findings indicate th
at postprandial lipoproteins alter markers of hemostasis positively in an a
ntithrombotic and profibrinolytic direction. In addition, triglyceride-lowe
ring treatment with etofibrate only slightly improves markers of fasting an
d postprandial hemostasis in an antithrombotic and profibrinolytic directio
n. (C) 1999 Elsevier Science Ltd. All rights reserved.